Nureca Current Share Price | Nureca Stock Screener
NURECA
Medical Equipment
Nureca Current Stock Price Today
Live Share Price NSE
₹342.60
▲
3.95 (1.17%)
Live Share Price BSE
₹342.40
▲
10.40 (3.13%)
As of August 7, 2026, the live Nureca share price (NSE: NURECA) is ₹342.60 on NSE and ₹342.40 on BSE, up 1.17% from the previous close, with shares trading between ₹332.55 and ₹348.00 in today's trading session, and a 52-week range of ₹206.75–₹343.95.
Browse Nureca financial data to support your investment research.
Use the Nureca stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Nureca Market Cap
₹307.44 Cr.
NURECA P/E Ratio (TTM)
73.56
Nureca P/B Ratio
1.80
EPS (TTM)
₹2.11
Dividend Yield
-
Debt to Equity
0.02
NURECA 52 Week High
₹343.95
Nureca 52 Week Low
₹206.75
Operating Margin
-16.00%
Profit Margin
-16.67%
NURECA Revenue (TTM)
₹36.00
EBITDA
₹-5.00
Net Income
₹-6.00
Total Assets
₹196.00
Total Equity
₹181.00
Nureca Current Share Price Chart
Track the current Nureca share price and stock price with an interactive chart. Analyse NURECA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Nureca stock quote in one place.
Nureca Company Profile - Fundamental Screener
Screen Nureca company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NURECA shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE0DSF01015
Nureca Balance Sheet Screener
Screen NURECA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 196 | 210 | 205 | 207 | 219 | 186 | 34 | 24 |
| Current Assets | 115 | 190 | 193 | 187 | 206 | 181 | 33 | 23 |
| Fixed Assets | 14 | 9 | 7 | 9 | 10 | 4 | 1 | 1 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 3 | 3 | 3 | 4 | 4 | 9 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 181 | 194 | 193 | 195 | 203 | 163 | 15 | 8 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 0 | 0 |
| Reserves & Surplus | 171 | 184 | 183 | 185 | 193 | 153 | 15 | 8 |
Nureca Income Statement Screener - Profit & Revenue Analysis
Screen Nureca income statement and profit fundamentals.
Analyze NURECA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Nureca share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36 | 42 | 34 | 37 | 40 | 42 | 16 | 26 | 34 | 28 | 23 | 24 | 35 | 28 | 43 |
| Expenses | 41 | 37 | 31 | 35 | 35 | 36 | 21 | 23 | 34 | 31 | 25 | 24 | 30 | 27 | 44 |
| EBITDA | -5 | 5 | 3 | 2 | 6 | 5 | -6 | 3 | 1 | -3 | -1 | 0 | 5 | 2 | -1 |
| Operating Profit % | -16.00% | 8.00% | 4.00% | -2.00% | 9.00% | 8.00% | -26.00% | -12.00% | -8.00% | -15.00% | -16.00% | -14.00% | 4.00% | -19.00% | -7.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -6 | 4 | 2 | 1 | 5 | 5 | -7 | 3 | 0 | -3 | -2 | -1 | 4 | 1 | -2 |
| Tax | 1 | 1 | 0 | 0 | 1 | 1 | -2 | 1 | 0 | -1 | 0 | 0 | 1 | 1 | -1 |
| Net Profit | -6 | 3 | 3 | 1 | 4 | 4 | -4 | 2 | -1 | -3 | -2 | -1 | 3 | 0 | -1 |
| EPS | -6.45 | 3.21 | 2.47 | 0.81 | 3.63 | 3.91 | -4.15 | 1.66 | -0.48 | -2.80 | -1.53 | -0.71 | 2.90 | 0.16 | -1.40 |
Nureca Cash Flow Screener - Liquidity Fundamentals
Screen NURECA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | -19 | -3 | 10 | 1 | 35 | -8 | 0 |
| Investing Activities | 15 | 8 | 18 | -17 | -3 | -110 | 0 | 0 |
| Financing Activities | -20 | 0 | -1 | -2 | -7 | 92 | 8 | 0 |
| Net Cash Flow | -2 | -11 | 14 | -8 | -9 | 17 | 0 | 0 |
Nureca Shareholding Pattern Screener
See Nureca shareholding pattern with promoter, FII, and DII holdings.
Check Nureca promoter holding and ownership changes for NURECA on TickJournal.
| Item | 2026-Jan | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.09% | 68.09% | 68.09% | 64.30% | 64.33% | 64.97% | 64.97% | 63.24% |
| FII Holding | 0.08% | 0.28% | 0.11% | 1.07% | 0.08% | 0.08% | 0.08% | 0.08% |
| DII Holding | 0.04% | 0.24% | 0.24% | 0.04% | 0.04% | 0.04% | 0.04% | 0.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.73% | 28.83% | 29.06% | 32.39% | 33.12% | 32.15% | 32.95% | 33.73% |
| Other Holding | 2.06% | 2.56% | 2.51% | 2.20% | 2.45% | 2.77% | 1.97% | 2.94% |
| Shareholder Count | 35,800 | 34,558 | 33,979 | 39,304 | 38,075 | 37,468 | 35,801 | 45,996 |
Nureca Share Dividend Screener - Share Yield Analysis
Check Nureca dividend history with payout and yield data.
View Nureca dividend details including ex-dates and amounts for NURECA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹3.00 | 1.00% |
| 2021-March | ₹2.00 | 0.15% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Nureca Stock Index Membership
See which indices include Nureca stock.
Check NURECA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Nureca Market Events Screener - Corporate Actions
Get Nureca corporate actions including splits, bonuses, and buybacks.
Check Nureca stock events that may affect NURECA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-28 | 2026-07-28 | Annual General Meeting | NA | 14.13% |
| 2026-07-21 | 2026-07-21 | Quarterly Result Announcement | NA | 14.63% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 1.55% |
| 2026-01-17 | 2026-01-17 | Quarterly Result Announcement | NA | 9.95% |
| 2025-12-12 | 2025-12-18 | Buyback | 330 | -1.09% |
| 2025-10-16 | 2025-10-16 | Quarterly Result Announcement | NA | 2.50% |
| 2025-07-15 | 2025-07-15 | Quarterly Result Announcement | NA | 1.19% |
| 2025-06-16 | 2025-06-16 | Annual General Meeting | NA | 21.94% |
| 2025-05-05 | 2025-05-05 | Quarterly Result Announcement | NA | -7.74% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | -7.31% |
| 2024-10-24 | 2024-10-24 | Quarterly Result Announcement | NA | -0.10% |
| 2024-07-18 | 2024-07-18 | Annual General Meeting | NA | -0.86% |
| 2022-02-24 | 2022-02-25 | Dividend | ₹ 3.00 /share | -18.28% |
| 2021-09-21 | 2021-09-23 | Dividend | ₹ 2.00 /share | 5.49% |
Nureca Competitors Screener - Peer Comparison
Screen NURECA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 17,278 | 56.28 | 1,995 | 13.43% | 321 | 45.68 |
| Tarsons Products | 1,613 | 149.19 | 447 | 9.38% | 14 | 37.47 |
| Q-Line Biotech | 1,578 | 30.40 | 342 | 5.93% | 56 | 65.34 |
| Laxmi Dental | 1,085 | 35.93 | 272 | 12.00% | 22 | 43.39 |
| Vasa Denticity | 670 | 59.91 | 279 | 10.97% | 10 | 41.41 |
| Fabtech Technologies | 650 | 13.49 | 411 | 22.29% | 36 | 42.61 |
| Hemant Surgical Industries | 644 | 37.43 | 232 | 107.34% | 19 | 62.54 |
| Osel Devices | 644 | 22.66 | 293 | 56.84% | 30 | 38.50 |
| Prevest Denpro | 456 | 22.49 | 77 | 14.31% | 21 | 45.23 |
| QMS Medical Allied Services | 321 | 24.27 | 173 | 9.63% | 12 | 71.02 |
Nureca Company Announcements - News Screener
Screen NURECA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-15 | "Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) | - |
| 2026-09-15 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-15 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-14 | Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 ( PIT Regulations ) | - |
| 2026-08-29 | Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) | - |
| 2026-08-11 | Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 ( PIT Regulations ). | - |
| 2026-08-10 | Additional Details Required For Corporate Announcement Under Regulation 30(4) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-07 | Pendency Of Litigation(S)/Dispute(S) Or The Outcome Impacting The Company. | - |
| 2026-07-28 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-07-28 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-21 | Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-21 | Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30 2026. | - |
| 2026-07-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-14 | Board Meeting Intimation for Nureca Limited Has Informed The Exchange Regarding Board Meeting Date For The Declaration Of Unaudited Financial Results For The Quarter Ended June 302026 And Other Business Matters. | - |
| 2026-07-09 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-08 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-08 | Reg. 34 (1) Annual Report. | - |
| 2026-07-06 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |